ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1285

Comparision of Urate Burden in Well and Poorly Controlled Gout Patients: A Dual-Energy CT Study

Min Kyung Chung1, Hyeran Hyun2, Ji Young Hwang2 and Jisoo Lee1, 1Division of Rheumatology, Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Korea, Republic of (South), 2Department of Radiology, Ewha Womans University School of Medicine, Seoul, Korea, Republic of (South)

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Computed tomography (CT), Gout and uric acid, Imaging

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, October 22, 2018

Title: Metabolic and Crystal Arthropathies – Basic and Clinical Science Poster I

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Dual-energy computed tomography (DECT) allows sensitive and quantative detection of monosodium urate (MSU) crystals in patients with gout. Although its usefulness in diagnosing gout is well defined, its role in monitoring changes of MSU depositions after urate lowering therpy (ULT) is unclear. The aim of our study was to investigate the difference in MSU deposition amount and pattern detected by DECT in well and poorly controlled gout patients.

Methods: DECT scans of feet and ankles were performed in 109 gout patients. Sixteen joints of ankles and feet, and achilles tendon insertion sites were evaluated for the presence of MSU deposition. The total volume of MSU deposition was quantified using an automated software program of DECT. Clinical, laboratory, and radiologic features were obtained at the time of DECT evaluation. Patients who maintained serum uric acid (sUA) level < 6.0mg/dL for more than 6 months prior to DECT evaluation were considered ‘well-controlled’ and otherwise, ‘poorly-controlled’.

Results: Twenty-five (22.9%) well-controlled patients were compared with 84 (77.1%) poorly-controlled. Well-controlled group showed mean sUA of 4.97±0.84mg/dL while poorly-controlled group showed mean sUA of 8.01±1.78mg/dL. Well-controlled group had significantly lower mean volume of MSU deposition compared with the poorly-controlled group (0.12cm3 vs 0.78cm3, p=0.001), and had lower number of MSU deposition (2 vs 4, p=0.002). Although volume and number of MSU depositions were significantly decreased, MSU depositions were still detected in the well-controlled group. In well-controlled group, MSU depositions were less frequently detected in MTP and ankle joints compared with the poorly-controlled group, whearas frequency of MSU deposition was not significantly different in the Chopart joint and Achilles tendon sites.

Conclusion: Well-controlled gout patients showed significantly reduced urate burden. However, since MSU deposition does not completely resolve even in well-controlled pateints, continuous ULT is recommended for optimal management of the gout patients.


Disclosure: M. K. Chung, None; H. Hyun, None; J. Y. Hwang, None; J. Lee, None.

To cite this abstract in AMA style:

Chung MK, Hyun H, Hwang JY, Lee J. Comparision of Urate Burden in Well and Poorly Controlled Gout Patients: A Dual-Energy CT Study [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/comparision-of-urate-burden-in-well-and-poorly-controlled-gout-patients-a-dual-energy-ct-study/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/comparision-of-urate-burden-in-well-and-poorly-controlled-gout-patients-a-dual-energy-ct-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology